Optimizing anticoagulation for patients receiving Impella support-Reference-Cited by-同舟云学术

Optimizing anticoagulation for patients receiving Impella support

Published:2021-11 Issue:11 Volume:41 Page:932-942
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Beavers Craig J.¹^ORCID,DiDomenico Robert J.²^ORCID,Dunn Steven P.³^ORCID,Cox Jenna⁴,To Long⁵,Weeks Phillip⁶^ORCID,Trujillo Toby C.⁷,Jennings Douglas L.⁸⁹^ORCID

Affiliation:

1. University of Kentucky College of Pharmacy Lexington Kentucky USA

2. Department of Pharmacy Practice University of Illinois Chicago College of Pharmacy Chicago Illinois USA

3. Department of Pharmacy University of Virginia Heart and Vascular Center Charlottesville Virginia USA

4. Department of Pharmacy Prisma Health Richland Hospital Columbia South Carolina USA

5. Department of Pharmacy Henry Ford Health System Detroit Michigan USA

6. Department of Pharmacy Memorial Hermann Health System Houston Texas USA

7. University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences/University of Colorado Hospital Denver Colorado USA

8. Arnold & Marie Schwartz College of Pharmacy and Health Sciences Department of Pharmacy Practice Long Island University New York New York USA

9. Department of Pharmacy New York‐Presbyterian Hospital Columbia University Medical Center New York New York USA

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2629

Reference61 articles.

1. Trends in Incidence, Management, and Outcomes of Cardiogenic Shock Complicating ST‐Elevation Myocardial Infarction in the United States

2. Ten‐Year (2001–2011) Trends in the Incidence Rates and Short‐Term Outcomes of Early Versus Late Onset Cardiogenic Shock After Hospitalization for Acute Myocardial Infarction

3. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association;Diepen S;Circulation,2017

4. Cardiogenic shock during heart failure hospitalizations: Age-, sex-, and race-stratified trends in incidence and outcomes

5. The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facility-based approach for the management of acute ST segment elevation myocardial infarction with cardiogenic shock in a rural medical centre: the Durango model;Open Heart;2023-12

2. A case series analysis of bicarbonate-based purge solution administration via Impella ventricular assist device;American Journal of Health-System Pharmacy;2023-11-11

3. Safety and Effectiveness of an Anti-Xa-based Unfractionated Heparin Protocol for Impella Percutaneous Ventricular Assist Devices;Hospital Pharmacy;2023-11-07

4. Current and future options for adult biventricular assistance: a review of literature;Frontiers in Cardiovascular Medicine;2023-11-06

5. Vascular Access Management in Complex Percutaneous Coronary Interventions;US Cardiology Review;2023-10-20